Skip to main content

+91-9888895871
+91-9814421587
pharvaxbio@gmail.com

Facebook Twitter Linkedin Pinterest Instagram

Menu

Home
About Us
PCD Pharma Franchise
Our Pharma Products
- By Form
  - Tablets
  - Capsules
  - Soft Gel Capsules
  - Injection
  - Syrup
  - Drops
  - Ointments
  - Eye/Nasal Drops
  - Protein Powder
  - Energy Drink
- By Specialities
Contact Us
Quick Links

Menu

Home
About Us
PCD Pharma Franchise
Our Pharma Products
- By Form
  - Tablets
  - Capsules
  - Soft Gel Capsules
  - Injection
  - Syrup
  - Drops
  - Ointments
  - Eye/Nasal Drops
  - Protein Powder
  - Energy Drink
- By Specialities
Contact Us
Quick Links

Amoxycillin and Potassium Clavulanic Acid Oral Suspension

Home » Amoxycillin and Potassium Clavulanic Acid Oral Suspension

Home / Paediatric Range / Amoxycillin and Potassium Clavulanic Acid Oral Suspension

Amoxycillin and Potassium Clavulanic Acid Oral Suspension

OURMOX-CV DS 457

SKU: 341dcdb592ab Category: Paediatric Range

Additional information

Additional information

PACKING	30ml

Related products

Cefuroxime Dry Syrup
Read more
Mefenamic and Paracetamol Suspension
Read more
Bacillus Clausi Spores Suspension
Read more
OURMOX-CV DRY
Read more

Pharvax Biosciences is a pharma company based in India, Having head office located in Panchkula

Quick Links

Home
About Us
Third Party Manufacturing
PCD Pharma Franchise
Pharma Distributionship
Contact Us

Our Product

Tablets
Capsules
Injection
Ointment
Syrup

Contact With Us

Plot No. 138, Second-floor Phase 2, Industrial Area, Panchkula, Haryana 134113
+91-9888895871
+91-9814421587
pharvaxbio@gmail.com

Facebook Twitter Linkedin Pinterest Instagram

© 2026 Pharvax Biosciences. All Rights Reserved. || Web Development and Marketed by WebHopers.

Call us
whatsapp
Download Product List

×

×

Apply For PCD Pharma Franchise

Leave this field empty

What is $Refresh icon$ $Refreshing captcha$

Solve the math problem shown in the image to continue.

Leave this field empty

What is $Refresh icon$ $Refreshing captcha$

Solve the math problem shown in the image to continue.